Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ENROLLING BY INVITATION
NCT06919640
PHASE1

Psilocybin With Intracranial Neural Sensing

Sponsor: Joshua Woolley, MD, PhD

View on ClinicalTrials.gov

Summary

This is an open-label, single-arm, pilot study exploring the neural, sensory, and cognitive effects of a single, medium dose of psilocybin in patients with chronic pain who already have implanted sensing-capable deep brain stimulation (DBS) devices. Outcomes include multi-site neural recording from previously placed ambulatory sensing-capable DBS devices, quantitative sensory and cognitive testing, and self-reports of pain. We hypothesize that psilocybin will change functional connectivity, decrease clinical and task-based pain reports, and improve cognitive functions.

Key Details

Gender

All

Age Range

21 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

20

Start Date

2025-06-01

Completion Date

2028-04-30

Last Updated

2025-06-06

Healthy Volunteers

No

Conditions

Interventions

DRUG

Psilocybin

10mg oral psilocybin

Locations (1)

University of California, San Francisco

San Francisco, California, United States